Australia TGA ARTG record

Suprasorb Liquacel Ag - Cavity-wound management dressing, antimicrobial

Australia TGA ARTG Registered Device · Lohmann & Rauscher Pty Ltd · Speciality Fibres and Materials Ltd · Class III · Started September 06, 2023

Good Name: Lohmann & Rauscher Pty Ltd - Suprasorb Liquacel Ag - Cavity-wound management dressing, antimicrobial

Device classification

Risk Class: Class III
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: September 06, 2023
Effective Date: September 06, 2023

Sponsor

Name: Lohmann & Rauscher Pty Ltd

Manufacturer

Name: Speciality Fibres and Materials Ltd
Country: United Kingdom
Address: Galaxy House 31 Herald Way Binley Industrial Estate, Coventry, CV3 2RQ

Intended purpose

Suprasorb Liquacel Ag antimicrobial wound dressings can be used for the management of moderately to heavily exuding wounds.

About this record

Access comprehensive regulatory information for Suprasorb Liquacel Ag - Cavity-wound management dressing, antimicrobial in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Lohmann & Rauscher Pty Ltd, manufactured by Speciality Fibres and Materials Ltd in United Kingdom. The device registration started on September 06, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.